
Sign up to save your podcasts
Or
On Monday, the FTC told Illumina to dissolve their acquisition with the multi-cancer early detection test company Grail. David Lim talks with host Ben Leonard about what this move means for the development and commercialization of cancer tests in the United States.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4.7
453453 ratings
On Monday, the FTC told Illumina to dissolve their acquisition with the multi-cancer early detection test company Grail. David Lim talks with host Ben Leonard about what this move means for the development and commercialization of cancer tests in the United States.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4,338 Listeners
610 Listeners
1,524 Listeners
635 Listeners
111,501 Listeners
976 Listeners
308 Listeners
56,177 Listeners
108 Listeners
467 Listeners
207 Listeners
131 Listeners
391 Listeners
28 Listeners
4 Listeners